Stay at the forefront of muscle-invasive bladder cancer (MIBC) with this webinar recording.
Join leading clinicians and innovators as they discuss the latest data from ESMO 2025 and explore how these findings could shape the future of patient care and clinical practice.
Interact and hear directly from the experts participating in the pivotal clinical trials such as KEYNOTE 905, SunRISe-4, and Bladder Path.
Seize this opportunity to enhance your clinical practice by expanding your knowledge and engaging with the experts.
Speakers:
- Prof. J. Aning (GB)
- Dr. B. Pradère (FR)
- Prof. N. James (GB)
- Prof. Dr. J. Bedke (DE)
This recording is brought to you in collaboration with the EAU Section of Oncological Urology. Acknowledgment This activity is supported by an educational grant from our industry partner MSD, with no involvement in the programme or speaker selection: https://www.msd.com/
🌟 Important info: The recording of this webinar is not EU-ACME accredited. Missed the live session? Earn 1 CME point by completing our online e-course at: https://uroweb.org/education-events/education?page=1&type=e-course. Don’t miss this opportunity! 🎓💡